154 
(E) The Department of Homeland Security, 
including the United States Coast Guard, the bu-
reau of Customs and Border Protection, and the 
bureau of Immigration and Customs Enforce-
ment. 
(F) The Department of Justice, including 
the National Drug Intelligence Center (NDIC); 
the Drug Enforcement Administration, including 
the El Paso Intelligence Center (EPIC); the Fed-
eral Bureau of Investigation; the Organized 
Crime Drug Enforcement Task Force; and the 
Regional Information Sharing System. 
(G) The Office of National Drug Control 
Policy, including the High Intensity Drug Traf-
ficking Areas Program. 
(H) The Counterdrug Intelligence Executive 
Secretariat. 
(2) PURPOSE.—The purpose of the plan under 
paragraph (1) is to maximize the effectiveness of the 
centers and activities referred to in that paragraph in 
achieving the objectives of the National Drug Control 
Strategy promulgated under 21 U.S.C. 1705. In order 
to maximize such effectiveness, the plan shall— 
(A) articulate clear and specific mission 
statements (including purpose and scope of ac-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00154
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
155 
tivity) for each counterdrug intelligence center, 
system, and activity, including the manner in 
which responsibility for counterdrug intelligence 
activities 
will 
be 
allocated 
among 
the 
counterdrug intelligence centers and systems; 
(B) specify each government agency (wheth-
er Federal, State, or local) that participates in 
each such center, system, and activity, including 
a description of the extent and nature of that 
participation; 
(C) specify the relationship between such 
centers, systems, and activities; 
(D) specify the means by which proper over-
sight of such centers, systems, and activities will 
be assured; 
(E) specify the means by which counterdrug 
intelligence and information will be forwarded 
effectively to all levels of officials responsible for 
United States counterdrug policy; and 
(F) specify mechanisms to ensure that State 
and local law enforcement agencies are apprised 
of counterdrug intelligence and information ac-
quired by Federal law enforcement agencies in a 
manner which— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00155
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
156 
(i) facilitates effective counterdrug ac-
tivities by State and local law enforcement 
agencies; and 
(ii) provides such State and local law 
enforcement agencies with the information 
relating to the safety of officials involved in 
their counterdrug activities. 
(3) DEFINITIONS.—As used in this subsection— 
(A) the term ‘‘center’’ refers to any center, 
office, task force, or other coordinating organiza-
tion engaged in counterdrug intelligence or infor-
mation analyzing or sharing activities; 
(B) the term ‘‘system’’ refers to any comput-
erized database or other electronic system used 
for counterdrug intelligence or information ana-
lyzing or sharing activities; and 
(C) the term ‘‘appropriate congressional 
committees’’ means the following: 
(i) The Committee on Appropriations, 
the Committee on Foreign Relations, the 
Committee on the Judiciary, the Committee 
on Homeland Security and Governmental 
Affairs, the Caucus on International Nar-
cotics Control, and the Select Committee on 
Intelligence of the Senate. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00156
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
157 
(ii) The Committee on Appropriations, 
the Committee on International Relations, 
the Committee on the Judiciary, the Com-
mittee on Government Reform, the Com-
mittee on Homeland Security, and the Per-
manent Select Committee on Intelligence of 
the House of Representatives. 
(4) LIMITATION.—The general counterdrug intel-
ligence plan shall not— 
(A) change existing agency authorities or 
the laws governing interagency relationships, but 
may include recommendations about changes to 
such authorities or laws; or 
(B) include any information about specific 
methods of obtaining, or sources of, intelligence 
or information, or any information about spe-
cific individuals, cases, investigations, or oper-
ations. 
(5) CLASSIFIED
OR
LAW
ENFORCEMENT
SEN-
SITIVE
INFORMATION.—Any content of the general 
counterdrug intelligence plan that involves informa-
tion classified under criteria established by an Execu-
tive order, or whose public disclosure, as determined 
by the Director of the Office of National Drug Control 
Policy, the Director of National Intelligence, or the 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00157
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
158 
head of any Federal Government agency whose activi-
ties are described in the plan, would be detrimental 
to the law enforcement or national security activities 
of any Federal, State, or local agency, shall be pre-
sented to Congress separately from the rest of the re-
port. 
(l) REQUIREMENT FOR SOUTHWEST BORDER COUN-
TERNARCOTICS STRATEGY.— 
(1) IN GENERAL.—Not later than 120 days after 
the date of enactment of this Act, and every two years 
thereafter, the Director of National Drug Control Pol-
icy shall submit to the Congress a Southwest Border 
Counternarcotics Strategy. 
(2) PURPOSES.—The Southwest Border Counter-
narcotics Strategy shall— 
(A) set forth the Government’s strategy for 
preventing the illegal trafficking of drugs across 
the international border between the United 
States and Mexico, including through ports of 
entry and between ports of entry on that border; 
(B) state the specific roles and responsibil-
ities of the relevant National Drug Control Pro-
gram agencies (as defined in section 702 of the 
Office of National Drug Control Policy Reau-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00158
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
159 
thorization Act of 1998 (21 U.S.C. 1701)) for 
implementing that strategy; and 
(C) identify the specific resources required 
to enable the relevant National Drug Control 
Program agencies to implement that strategy. 
(3) CONSULTATION
WITH
OTHER
AGENCIES.— 
The Director shall issue the Southwest Border Coun-
ternarcotics Strategy in consultation with the heads 
of the relevant National Drug Control Program agen-
cies. 
(4) LIMITATION.—The Southwest Border Coun-
ternarcotics Strategy shall not change existing agency 
authorities or the laws governing interagency rela-
tionships, but may include recommendations about 
changes to such authorities or laws. 
(5) REPORT TO CONGRESS.—The Director shall 
provide a copy of the Southwest Border Counter-
narcotics Strategy to the appropriate congressional 
committees (as defined in section 702 of the Office of 
National Drug Control Policy Reauthorization Act of 
1998 (21 U.S.C. 1701)), and to the Committee on 
Armed Services and the Committee on Homeland Se-
curity of the House of Representatives, and the Com-
mittee on Homeland Security and Governmental Af-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00159
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
160 
fairs and the Committee on Armed Services of the 
Senate. 
(6) TREATMENT
OF
CLASSIFIED
OR
LAW
EN-
FORCEMENT SENSITIVE INFORMATION.—Any content 
of the Southwest Border Counternarcotics Strategy 
that involves information classified under criteria es-
tablished by an Executive order, or whose public dis-
closure, as determined by the Director or the head of 
any relevant National Drug Control Program agency, 
would be detrimental to the law enforcement or na-
tional security activities of any Federal, State, or 
local agency, shall be presented to Congress separately 
from the rest of the strategy. 
(m) REQUIREMENT
FOR
SCIENTIFIC
STUDY
OF 
MYCOHERBICIDE IN ILLICIT DRUG CROP ERADICATION.— 
Not later than 90 days after the date of enactment of this 
Act, the Director of the Office of National Drug Control Pol-
icy shall submit to the Congress a report that includes a 
plan to conduct, on an expedited basis, a scientific study 
of the use of mycoherbicide as a means of illicit drug crop 
elimination by an appropriate Government scientific re-
search entity, including a complete and thorough scientific 
peer review. The study shall include an evaluation of the 
likely human health and environmental impacts of such use. 
The report shall also include a plan to conduct controlled 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00160
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
161 
scientific testing in a major drug producing nation of 
mycoherbicide naturally existing in the producing nation. 
SEC. 7. AMENDMENTS RELATING TO COORDINATION WITH 
OTHER AGENCIES. 
Section 705 (21 U.S.C. 1704) is amended— 
(1) in subsection (a)(1)(A), by striking ‘‘abuse’’; 
(2) in subsection (a)(2)(A), by striking ‘‘Director 
of Central Intelligence’’ and inserting ‘‘Director of 
National Intelligence’’; 
(3) in subsection (a)(2)(B), by striking ‘‘Director 
of Central Intelligence’’ and inserting ‘‘Director of 
National Intelligence and the Director of the Central 
Intelligence Agency’’; 
(4) by amending paragraph (3) of subsection (a) 
to read as follows: 
‘‘(3) REQUIRED REPORTS.— 
‘‘(A) SECRETARIES OF THE INTERIOR AND 
AGRICULTURE.—The Secretaries of Agriculture 
and Interior shall, by July 1 of each year, joint-
ly submit to the Director, the appropriate con-
gressional committees, the Committee on Agri-
culture and the Committee on Resources of the 
House of Representatives, and the Committee on 
Agriculture and the Committee on Energy and 
Natural Resources of the Senate, an assessment 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00161
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
162 
of the quantity of illegal drug cultivation and 
manufacturing in the United States on lands 
owned or under the jurisdiction of the Federal 
Government for the preceding year. 
‘‘(B) ATTORNEY
GENERAL.—The Attorney 
General shall, by July 1 of each year, submit to 
the Director and the appropriate congressional 
committees information for the preceding year 
regarding the number and type of— 
‘‘(i) arrests for drug violations; 
‘‘(ii) prosecutions for drug violations 
by United States Attorneys; and 
‘‘(iii) seizures of drugs by each compo-
nent of the Department of Justice seizing 
drugs, as well as statistical information on 
the geographic areas of such seizures. 
‘‘(C) SECRETARY
OF
HOMELAND
SECU-
RITY.—The Secretary of Homeland Security 
shall, by July 1 of each year, submit to the Di-
rector, the appropriate congressional committees, 
and the Committee on Homeland Security of the 
House of Representatives, and the Committee on 
Homeland Security and Governmental Affairs of 
the Senate, information for the preceding year 
regarding— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00162
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
163 
‘‘(i) the number and type of seizures of 
drugs by each component of the Department 
of Homeland Security seizing drugs, as well 
as statistical information on the geographic 
areas of such seizures; and 
‘‘(ii) the number of air and maritime 
patrol hours undertaken by each component 
of that Department primarily dedicated to 
drug supply reduction missions. 
‘‘(D) SECRETARY OF DEFENSE.—The Sec-
retary of Defense shall, by July 1 of each year, 
submit to the Director, the appropriate congres-
sional committees, the Committee on Armed 
Services of the House of Representatives, and the 
Committee on Armed Services of the Senate, in-
formation for the preceding year regarding the 
number of air and maritime patrol hours pri-
marily dedicated to drug supply reduction mis-
sions undertaken by each component of the De-
partment of Defense.’’; 
(5) in subsection (b)(2)(B), by striking ‘‘Pro-
gram.’’ and inserting ‘‘Strategy.’’; and 
(6) in subsection (c), by striking ‘‘in’’ and in-
serting ‘‘on’’. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00163
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
164 
SEC. 8. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
Section 706 (21 U.S.C. 1705) is amended to read as 
follows: 
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVELOP-
MENT
AND SUBMISSION
OF NATIONAL DRUG CONTROL 
STRATEGY.— 
‘‘(1) IN GENERAL.—Not later than February 1 of 
each year, the President shall submit to Congress a 
National Drug Control Strategy, which shall set forth 
a comprehensive plan for reducing illicit drug use 
and the consequences of illicit drug use in the United 
States by reducing the demand for illegal drugs, lim-
iting the availability of illegal drugs, and conducting 
law enforcement activities with respect to illegal 
drugs. 
‘‘(2) CONTENTS.— 
‘‘(A) IN
GENERAL.—The National Drug 
Control Strategy submitted under paragraph (1) 
shall include the following: 
‘‘(i) 
Comprehensive, 
research-based, 
long-range, and quantifiable goals for re-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00164
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
165 
ducing illicit drug use and the consequences 
of illicit drug use in the United States. 
‘‘(ii) Annual quantifiable objectives for 
demand reduction, supply reduction, and 
law enforcement activities, specific targets 
to accomplish long-range quantifiable reduc-
tion in illicit drug use as determined by the 
Director, and specific measurements to 
evaluate progress toward the targets and 
strategic goals. 
‘‘(iii) A strategy to reduce the avail-
ability and purity of illegal drugs and the 
level of drug-related crime in the United 
States. 
‘‘(iv) An assessment of Federal effec-
tiveness in achieving the National Drug 
Control Strategy for the previous year, in-
cluding a specific evaluation of whether the 
objectives and targets for reducing illicit 
drug use for the previous year were met and 
reasons for the success or failure of the pre-
vious year’s Strategy. 
‘‘(v) A general review of the status of, 
and trends in, international, State, and 
local drug control activities to ensure that 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00165
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
166 
the United States pursues well-coordinated 
and effective drug control at all levels of 
government. 
‘‘(vi) A general review of the status of, 
and trends in, demand reduction activities 
by private sector entities and community- 
based organizations, including faith-based 
organizations, to determine their effective-
ness and the extent of cooperation, coordina-
tion, and mutual support between such enti-
ties and organizations and Federal, State, 
and local government agencies. 
‘‘(vii) An assessment of current illicit 
drug use (including inhalants and steroids) 
and availability, impact of illicit drug use, 
and treatment availability, which assess-
ment shall include— 
‘‘(I) estimates of drug prevalence 
and frequency of use as measured by 
national, State, and local surveys of il-
licit drug use and by other special 
studies of nondependent and dependent 
illicit drug use; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00166
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
167 
‘‘(II) illicit drug use in the work-
place and the productivity lost by such 
use; and 
‘‘(III) illicit drug use by arrestees, 
probationers, and parolees. 
‘‘(viii) An assessment of the reduction 
of illicit drug availability, as measured 
by— 
‘‘(I) the quantities of cocaine, her-
oin, marijuana, methamphetamine, ec-
stasy, and other drugs available for 
consumption in the United States; 
‘‘(II) the amount of marijuana, 
cocaine, heroin, methamphetamine, ec-
stasy, and precursor chemicals and 
other drugs entering the United States; 
‘‘(III) the number of illicit drug 
manufacturing laboratories seized and 
destroyed and the number of hectares of 
marijuana, poppy, and coca cultivated 
and destroyed domestically and in 
other countries; 
‘‘(IV) the number of metric tons of 
marijuana, heroin, cocaine, and meth-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00167
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
168 
amphetamine seized and other drugs; 
and 
‘‘(V) changes in the price and pu-
rity of heroin, methamphetamine, and 
cocaine, changes in the price of ecstasy, 
and changes in tetrahydrocannabinol 
level of marijuana and other drugs. 
‘‘(ix) An assessment of the reduction of 
the consequences of illicit drug use and 
availability, which shall include— 
‘‘(I) the burden illicit drug users 
place on hospital emergency depart-
ments in the United States, such as the 
quantity of illicit drug-related services 
provided; 
‘‘(II) the annual national health 
care cost of illicit drug use; and 
‘‘(III) the extent of illicit drug-re-
lated crime and criminal activity. 
‘‘(x) A general review of the status of, 
and trends in, of drug treatment in the 
United States, by assessing— 
‘‘(I) public and private treatment 
utilization; and 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00168
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
169 
‘‘(II) the number of illicit drug 
users the Director estimates meet diag-
nostic criteria for treatment. 
‘‘(xi) A review of the research agenda 
of the Counterdrug Technology Assessment 
Center to reduce the availability and abuse 
of drugs. 
‘‘(xii) A summary of the efforts made 
by Federal agencies to coordinate with pri-
vate sector entities to conduct private re-
search and development of medications to 
treat addiction by— 
‘‘(I) screening chemicals for poten-
tial therapeutic value; 
‘‘(II) developing promising com-
pounds; 
‘‘(III) conducting clinical trials; 
‘‘(IV) seeking, where appropriate, 
Food and Drug Administration ap-
proval for drugs to treat addiction; 
‘‘(V) marketing, where appro-
priate, the drug for the treatment of 
addiction; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00169
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
170 
‘‘(VI) urging physicians, where 
appropriate, to use the drug in the 
treatment of addiction; and 
‘‘(VII) encouraging, where appro-
priate, insurance companies to reim-
burse the cost of the drug for the treat-
ment of addiction. 
‘‘(xiii) Such additional statistical data 
and information as the Director considers 
appropriate to demonstrate and assess 
trends relating to illicit drug use, the effects 
and consequences of illicit drug use, supply 
reduction, demand reduction, drug-related 
law enforcement, and the implementation of 
the National Drug Control Strategy. 
‘‘(xiv) A supplement reviewing the ac-
tivities of each individual National Drug 
Control Program agency during the pre-
vious year with respect to the National 
Drug Control Strategy and the Director’s 
assessment of the progress of each National 
Drug Control Program agency in meeting 
its responsibilities under the National Drug 
Control Strategy. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00170
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
171 
‘‘(B) CLASSIFIED INFORMATION.—Any con-
tents of the National Drug Control Strategy that 
involve information properly classified under 
criteria established by an Executive order shall 
be presented to Congress separately from the rest 
of the National Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFORMA-
TION.—In selecting data and information for in-
clusion under subparagraph (A), the Director 
shall ensure— 
‘‘(i) the inclusion of data and informa-
tion that will permit analysis of current 
trends against previously compiled data 
and information where the Director believes 
such analysis enhances long-term assessment 
of the National Drug Control Strategy; and 
‘‘(ii) the inclusion of data and infor-
mation to permit a standardized and uni-
form assessment of the effectiveness of drug 
treatment programs in the United States. 
‘‘(3) PROCESS FOR DEVELOPMENT AND SUBMIS-
SION.— 
‘‘(A) CONSULTATION.—In developing and 
effectively implementing the National Drug Con-
trol Strategy, the Director— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00171
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
172 
‘‘(i) shall consult with— 
‘‘(I) the heads of the National 
Drug Control Program agencies; 
‘‘(II) Congress; 
‘‘(III) State and local officials; 
‘‘(IV) private citizens and organi-
zations, including community- and 
faith-based organizations, with experi-
ence and expertise in demand reduc-
tion; 
‘‘(V) private citizens and organi-
zations with experience and expertise 
in supply reduction; 
‘‘(VI) private citizens and organi-
zations with experience and expertise 
in law enforcement; and 
‘‘(VII) appropriate representatives 
of foreign governments; 
‘‘(ii) with the concurrence of the Attor-
ney General, may require the El Paso Intel-
ligence Center to undertake specific tasks or 
projects to implement the National Drug 
Control Strategy; 
‘‘(iii) with the concurrence of the Di-
rector of National Intelligence and the At-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00172
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
173 
torney General, may request that the Na-
tional Drug Intelligence Center undertake 
specific tasks or projects to implement the 
National Drug Control Strategy; and 
‘‘(iv) may make recommendations to 
the Secretary of Health and Human Serv-
ices on research that supports or advances 
the National Drug Control Strategy. 
‘‘(B) COMMITMENT
TO
SUPPORT
STRAT-
EGY.—In satisfying the requirements of subpara-
graph (A)(i), the Director shall ensure, to the 
maximum extent possible, that State and local 
officials and relevant private organizations com-
mit to support and take steps to achieve the 
goals and objectives of the National Drug Control 
Strategy. 
‘‘(C) 
RECOMMENDATIONS.—Recommenda-
tions under subparagraph (A)(iv) may include 
recommendations of research to be performed at 
the National Institutes of Health, including the 
National Institute on Drug Abuse, or any other 
appropriate agency within the Department of 
Health and Human Services. 
‘‘(D) INCLUSION
IN
STRATEGY.—The Na-
tional Drug Control Strategy under this sub-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00173
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
174 
section shall include a list of each entity con-
sulted under subparagraph (A)(i). 
‘‘(4) SUBMISSION OF REVISED STRATEGY.—The 
President may submit to Congress a revised National 
Drug Control Strategy that meets the requirements of 
this section— 
‘‘(A) at any time, upon a determination by 
the President, in consultation with the Director, 
that the National Drug Control Strategy in effect 
is not sufficiently effective; or 
‘‘(B) if a new President or Director takes 
office. 
‘‘(b) PERFORMANCE MEASUREMENT SYSTEM.—Not 
later than February 1 of each year, the Director shall sub-
mit to Congress, as part of the National Drug Control 
Strategy, a description of a national drug control perform-
ance measurement system that— 
‘‘(1) develops 2-year and 5-year performance 
measures and targets for each National Drug Control 
Strategy goal and objective established for reducing 
drug use, drug availability, and the consequences of 
drug use; 
‘‘(2) describes the sources of information and 
data that will be used for each performance measure 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00174
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
175 
incorporated into the performance measurement sys-
tem; 
‘‘(3) identifies major programs and activities of 
the National Drug Control Program agencies that 
support the goals and annual objectives of the Na-
tional Drug Control Strategy; 
‘‘(4) evaluates the contribution of demand reduc-
tion and supply reduction activities implemented by 
each National Drug Control Program agency in sup-
port of the National Drug Control Strategy; 
‘‘(5) monitors consistency of drug-related goals 
and objectives among the National Drug Control Pro-
gram agencies and ensures that each agency’s goals, 
objectives, and budgets support and are fully con-
sistent with the National Drug Control Strategy; and 
‘‘(6) coordinates the development and implemen-
tation of national drug control data collection and re-
porting systems to support policy formulation and 
performance measurement, including an assessment 
of— 
‘‘(A) the quality of current drug use meas-
urement instruments and techniques to measure 
supply reduction and demand reduction activi-
ties; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00175
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
176 
‘‘(B) the adequacy of the coverage of exist-
ing national drug use measurement instruments 
and techniques to measure the illicit drug user 
population, and groups that are at risk for illicit 
drug use; and 
‘‘(C) the adequacy of the coverage of existing 
national treatment outcome monitoring systems 
to measure the effectiveness of drug abuse treat-
ment in reducing illicit drug use and criminal 
behavior during and after the completion of sub-
stance abuse treatment; and 
‘‘(7) identifies the actions the Director shall take 
to correct any inadequacies, deficiencies, or limita-
tions identified in the assessment described in para-
graph (6). 
‘‘(c) MODIFICATIONS.—A description of any modifica-
tions made during the preceding year to the national drug 
performance measurement system described in subsection 
(b) shall be included in each report submitted under sub-
section (a).’’. 
SEC. 9. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO-
GRAM. 
Section 707 (21 U.S.C. 1706) is amended to read as 
follows: 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00176
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
177 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.— 
‘‘(1) IN GENERAL.—There is established in the 
Office a program to be known as the High Intensity 
Drug Trafficking Areas Program (in this section re-
ferred to as the ‘Program’). 
‘‘(2) PURPOSE.—The purpose of the Program is 
to reduce drug trafficking and drug production in the 
United States by— 
‘‘(A) facilitating cooperation among Fed-
eral, State, and local law enforcement agencies to 
share information and implement coordinated 
enforcement activities; 
‘‘(B) enhancing intelligence sharing among 
Federal, State, and local law enforcement agen-
cies; 
‘‘(C) providing reliable intelligence to law 
enforcement agencies needed to design effective 
enforcement strategies and operations; and 
‘‘(D) supporting coordinated law enforce-
ment strategies which maximize use of available 
resources to reduce the supply of illegal drugs in 
designated areas and in the United States as a 
whole. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00177
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
178 
‘‘(b) DESIGNATION.—The Director, upon consultation 
with the Attorney General, the Secretary of the Treasury, 
the Secretary of Homeland Security, heads of the National 
Drug Control Program agencies, and the Governor of each 
applicable State, may designate any specified area of the 
United States as a high intensity drug trafficking area. 
After making such a designation and in order to provide 
Federal assistance to the area so designated, the Director 
may— 
‘‘(1) obligate such sums as are appropriated for 
the Program; 
‘‘(2) direct the temporary reassignment of Fed-
eral personnel to such area, subject to the approval of 
the head of the department or agency that employs 
such personnel; 
‘‘(3) take any other action authorized under sec-
tion 704 to provide increased Federal assistance to 
those areas; and 
‘‘(4) coordinate activities under this section (spe-
cifically administrative, recordkeeping, and funds 
management activities) with State and local officials. 
‘‘(c) PETITIONS
FOR DESIGNATION.—The Director 
shall establish regulations under which a coalition of inter-
ested law enforcement agencies from an area may petition 
for designation as a high intensity drug trafficking area. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00178
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
179 
Such regulations shall provide for a regular review by the 
Director of the petition, including a recommendation re-
garding the merit of the petition to the Director by a panel 
of qualified, independent experts. 
‘‘(d) FACTORS FOR CONSIDERATION.—In considering 
whether to designate an area under this section as a high 
intensity drug trafficking area, the Director shall consider, 
in addition to such other criteria as the Director considers 
to be appropriate, the extent to which— 
‘‘(1) the area is a significant center of illegal 
drug production, manufacturing, importation, or dis-
tribution; 
‘‘(2) State and local law enforcement agencies 
have committed resources to respond to the drug traf-
ficking problem in the area, thereby indicating a de-
termination to respond aggressively to the problem; 
‘‘(3) drug-related activities in the area are hav-
ing a significant harmful impact in the area, and in 
other areas of the country; and 
‘‘(4) a significant increase in allocation of Fed-
eral resources is necessary to respond adequately to 
drug-related activities in the area. 
‘‘(e) ORGANIZATION OF HIGH INTENSITY DRUG TRAF-
FICKING AREAS.— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00179
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
180 
‘‘(1) EXECUTIVE BOARD AND OFFICERS.—To be 
eligible for funds appropriated under this section, 
each high intensity drug trafficking area shall be gov-
erned by an Executive Board. The Executive Board 
shall designate a chairman, vice chairman, and any 
other officers to the Executive Board that it deter-
mines are necessary. 
‘‘(2) RESPONSIBILITIES.—The Executive Board 
of a high intensity drug trafficking area shall be re-
sponsible for— 
‘‘(A) providing direction and oversight in 
establishing and achieving the goals of the high 
intensity drug trafficking area; 
‘‘(B) managing the funds of the high inten-
sity drug trafficking area; 
‘‘(C) reviewing and approving all funding 
proposals consistent with the overall objective of 
the high intensity drug trafficking area; and 
‘‘(D) reviewing and approving all reports to 
the Director on the activities of the high inten-
sity drug trafficking area. 
‘‘(3) BOARD
REPRESENTATION.—None of the 
funds appropriated under this section may be ex-
pended for any high intensity drug trafficking area, 
or for a partnership or region of a high intensity 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00180
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
181 
drug trafficking area, if that area’s, region’s or part-
nership’s Executive Board does not apportion an 
equal number of votes between representatives of par-
ticipating Federal agencies and representatives of 
participating State and local agencies. Where it is 
impractical for a equal number of representatives of 
Federal agencies and State and local agencies to at-
tend a meeting of an Executive Board in person, the 
Executive Board may use a system of proxy votes or 
weighted votes to achieve the voting balance required 
by this paragraph. 
‘‘(4) NO AGENCY RELATIONSHIP.—The eligibility 
requirements of this section are intended to ensure the 
responsible use of Federal funds. Nothing in this sec-
tion is intended to create an agency relationship be-
tween individual high intensity drug trafficking areas 
and the Federal Government. 
‘‘(f) USE OF FUNDS.—The Director shall ensure that 
no Federal funds appropriated for the Program are ex-
pended for the establishment or expansion of drug treatment 
programs, and shall ensure that not more than five percent 
of the Federal funds appropriated for the Program are ex-
pended for the establishment of drug prevention programs. 
‘‘(g) COUNTERTERRORISM ACTIVITIES.— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00181
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
182 
‘‘(1) ASSISTANCE
AUTHORIZED.—The Director 
may authorize use of resources available for the Pro-
gram to assist Federal, State, and local law enforce-
ment agencies in investigations and activities related 
to terrorism and prevention of terrorism, especially 
but not exclusively with respect to such investigations 
and activities that are also related to drug trafficking. 
‘‘(2) LIMITATION.—The Director shall ensure— 
‘‘(A) that assistance provided under para-
graph (1) remains incidental to the purpose of 
the Program to reduce drug availability and 
carry out drug-related law enforcement activi-
ties; and 
‘‘(B) that significant resources of the Pro-
gram are not redirected to activities exclusively 
related to terrorism, except on a temporary basis 
under extraordinary circumstances, as deter-
mined by the Director. 
‘‘(h) ROLE
OF DRUG ENFORCEMENT ADMINISTRA-
TION.—The Director, in consultation with the Attorney 
General, shall ensure that a representative of the Drug En-
forcement Administration is included in the Intelligence 
Support Center for each high intensity drug trafficking 
area. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00182
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
183 
‘‘(i) ANNUAL HIDTA PROGRAM BUDGET SUBMIS-
SIONS.—As part of the documentation that supports the 
President’s annual budget request for the Office, the Direc-
tor shall submit to Congress a budget justification that in-
cludes the following: 
‘‘(1) The amount requested for each high inten-
sity drug trafficking area with supporting narrative 
descriptions and rationale for each request. 
‘‘(2) A detailed justification for each funding re-
quest that explains the reasons for the requested fund-
ing level, how such funding level was determined 
based on a current assessment of the drug trafficking 
threat in each high intensity drug trafficking area, 
how such funding will ensure that the goals and objec-
tives of each such area will be achieved, and how such 
funding supports the National Drug Control Strategy. 
‘‘(j) EMERGING THREAT RESPONSE FUND.— 
‘‘(1) IN GENERAL.—The Director may expend up 
to 10 percent of the amounts appropriated under this 
section on a discretionary basis, to respond to any 
emerging drug trafficking threat in an existing high 
intensity drug trafficking area, or to establish a new 
high intensity drug trafficking area or expand an ex-
isting high intensity drug trafficking area, in accord-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00183
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
184 
ance with the criteria established under paragraph 
(2). 
‘‘(2) CONSIDERATION OF IMPACT.—In allocating 
funds under this subsection, the Director shall con-
sider— 
‘‘(A) the impact of activities funded on re-
ducing overall drug traffic in the United States, 
or minimizing the probability that an emerging 
drug trafficking threat will spread to other areas 
of the United States; and 
‘‘(B) such other criteria as the Director con-
siders appropriate. 
‘‘(k) EVALUATION.— 
‘‘(1) INITIAL REPORT.—Not later than 90 days 
after the date of the enactment of this subsection, the 
Director shall, after consulting with the Executive 
Boards of each designated high intensity drug traf-
ficking area, submit a report to Congress that de-
scribes, for each designated high intensity drug traf-
ficking area— 
‘‘(A) the specific purposes for the high in-
tensity drug trafficking area; 
‘‘(B) the specific long-term and short-term 
goals and objectives for the high intensity drug 
trafficking area; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00184
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
185 
‘‘(C) the measurements that will be used to 
evaluate the performance of the high intensity 
drug trafficking area in achieving the long-term 
and short-term goals; and 
‘‘(D) the reporting requirements needed to 
evaluate the performance of the high intensity 
drug trafficking area in achieving the long-term 
and short-term goals. 
‘‘(2) EVALUATION OF HIDTA PROGRAM AS PART 
OF NATIONAL DRUG CONTROL STRATEGY.—For each 
designated high intensity drug trafficking area, the 
Director shall submit, as part of the annual National 
Drug Control Strategy report, a report that— 
‘‘(A) describes— 
‘‘(i) the specific purposes for the high 
intensity drug trafficking area; and 
‘‘(ii) the specific long-term and short- 
term goals and objectives for the high inten-
sity drug trafficking area; and 
‘‘(B) includes an evaluation of the perform-
ance of the high intensity drug trafficking area 
in accomplishing the specific long-term and 
short-term goals and objectives identified under 
paragraph (1)(B). 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00185
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
186 
‘‘(l) ASSESSMENT
OF DRUG ENFORCEMENT TASK 
FORCES IN HIGH INTENSITY DRUG TRAFFICKING AREAS.— 
Not later than 180 days after the date of enactment of this 
subsection, and as part of each subsequent annual National 
Drug Control Strategy report, the Director shall submit to 
Congress a report— 
‘‘(1) assessing the number and operation of all 
federally funded drug enforcement task forces within 
each high intensity drug trafficking area; and 
‘‘(2) describing— 
‘‘(A) each Federal, State, and local drug en-
forcement task force operating in the high inten-
sity drug trafficking area; 
‘‘(B) how such task forces coordinate with 
each other, with any high intensity drug traf-
ficking area task force, and with investigations 
receiving funds from the Organized Crime and 
Drug Enforcement Task Force; 
‘‘(C) what steps, if any, each such task force 
takes to share information regarding drug traf-
ficking and drug production with other federally 
funded drug enforcement task forces in the high 
intensity drug trafficking area; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00186
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
187 
‘‘(D) the role of the high intensity drug traf-
ficking area in coordinating the sharing of such 
information among task forces; 
‘‘(E) the nature and extent of cooperation 
by each Federal, State, and local participant in 
ensuring that such information is shared among 
law enforcement agencies and with the high in-
tensity drug trafficking area; 
‘‘(F) the nature and extent to which infor-
mation sharing and enforcement activities are 
coordinated with joint terrorism task forces in 
the high intensity drug trafficking area; and 
‘‘(G) any recommendations for measures 
needed to ensure that task force resources are uti-
lized efficiently and effectively to reduce the 
availability of illegal drugs in the high intensity 
drug trafficking areas. 
‘‘(m) ASSESSMENT
OF INTELLIGENCE SHARING
IN 
HIGH
INTENSITY
DRUG
TRAFFICKING
AREAS—PRO-
GRAM.—Not later than 180 days after the date of the enact-
ment of this subsection, and as part of each subsequent an-
nual National Drug Control Strategy report, the Director 
shall submit to Congress a report— 
‘‘(1) evaluating existing and planned intelligence 
systems supported by each high intensity drug traf-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00187
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
188 
ficking area, or utilized by task forces receiving any 
funding under the Program, including the extent to 
which such systems ensure access and availability of 
intelligence to Federal, State, and local law enforce-
ment agencies within the high intensity drug traf-
ficking area and outside of it; 
‘‘(2) the extent to which Federal, State, and local 
law enforcement agencies participating in each high 
intensity drug trafficking area are sharing intel-
ligence information to assess current drug trafficking 
threats and design appropriate enforcement strategies; 
and 
‘‘(3) the measures needed to improve effective 
sharing of information and intelligence regarding 
drug trafficking and drug production among Federal, 
State, and local law enforcement participating in a 
high intensity drug trafficking area, and between 
such agencies and similar agencies outside the high 
intensity drug trafficking area. 
‘‘(n) COORDINATION
OF
INTELLIGENCE
SHARING 
WITH ORGANIZED CRIME DRUG ENFORCEMENT TASK 
FORCE PROGRAM.—The Director, in consultation with the 
Attorney General, shall ensure that any drug enforcement 
intelligence obtained by the Intelligence Support Center for 
each high intensity drug trafficking area is shared, on a 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00188
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
189 
timely basis, with the drug intelligence fusion center oper-
ated by the Organized Crime Drug Enforcement Task Force 
of the Department of Justice. 
‘‘(o) USE OF FUNDS TO COMBAT METHAMPHETAMINE 
TRAFFICKING.— 
‘‘(1) IN GENERAL.— 
‘‘(A) REQUIREMENT.—The Director shall 
ensure that, of the amounts appropriated for a 
fiscal year for the Program, at least $15,000,000 
is allocated to combat the trafficking of meth-
amphetamine in areas designated by the Direc-
tor as high intensity drug trafficking areas. 
‘‘(B) ACTIVITIES.—In meeting the require-
ment in subparagraph (A), the Director shall 
transfer funds to appropriate Federal, State, and 
local governmental agencies for employing addi-
tional Federal law enforcement personnel, or fa-
cilitating the employment of additional State 
and local law enforcement personnel, including 
agents, investigators, prosecutors, laboratory 
technicians, chemists, investigative assistants, 
and drug prevention specialists. 
‘‘(2) APPORTIONMENT OF FUNDS.— 
‘‘(A) FACTORS
IN
APPORTIONMENT.—The 
Director shall apportion amounts allocated 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00189
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
190 
under paragraph (1) among areas designated by 
the Director as high intensity drug trafficking 
areas based on the following factors: 
‘‘(i) The number of methamphetamine 
manufacturing facilities discovered by Fed-
eral, State, or local law enforcement offi-
cials in the area during the previous fiscal 
year. 
‘‘(ii) The number of methamphetamine 
prosecutions in Federal, State, or local 
courts in the area during the previous fiscal 
year. 
‘‘(iii) The number of methamphet-
amine arrests by Federal, State, or local 
law enforcement officials in the area during 
the previous fiscal year. 
‘‘(iv) The amounts of methamphet-
amine or listed chemicals (as that term is 
defined in section 102(33) of the Controlled 
Substances Act (21 U.S.C. 802(33)) seized 
by Federal, State, or local law enforcement 
officials in the area during the previous fis-
cal year. 
‘‘(v) Intelligence and predictive data 
from the Drug Enforcement Administration 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00190
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS